✓ Medically Reviewed Monograph

Montelukast

Also known as / Synonyms: Montelukast sodium

Leukotriene receptor antagonist preventing asthma attacks and relieving seasonal allergy symptoms.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Montelukast
Active Ingredient: Montelukast sodium
Dosage Form: Tablet
Available Strengths: 10 mg tablets for adults; chewable tablets and granules use different strengths.
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Oral
Popular Verified Brands:
Montair Singulair (brand availability varies by market)
Regulatory Standards: Verify current Indian market authorisation, prescription status, and formulation labelling before publication.
🎯

Approved Indications & Medical Uses

Montelukast is a leukotriene receptor antagonist used as a regular controller medicine for selected patients with asthma and, in some cases, allergic rhinitis. It is not a rescue inhaler and will not stop a sudden asthma attack.

🚫

Contraindications (Do Not Use If…)

Do not take montelukast if you have had a serious allergic reaction to it or any ingredient in the product. Check formulation-specific age restrictions.

🛡️

Important Clinical Precautions & Warnings

Montelukast carries a warning about serious mood, behaviour, and sleep changes. Tell your doctor about any mental health history and watch for new agitation, anxiety, depression, unusual dreams, or suicidal thoughts. Do not stop other asthma medicines unless your doctor says so.

Special Populations (Paediatric & Geriatric Care)

Use the formulation and strength appropriate for the patient's age. Granules and chewable tablets come with specific instructions.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Common effects may include headache, stomach pain, cough, or upper respiratory symptoms — though experiences vary between people.

🚨 Serious Side Effects — Seek Urgent Medical Care

Get urgent help for suicidal thoughts, major mood or behaviour changes, a severe allergic reaction, or worsening breathing.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

Tell your doctor about all medicines, especially rifampicin and some seizure medicines, which can affect montelukast blood levels.

🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Your doctor should review montelukast during pregnancy, balancing asthma control needs against any available alternatives.

Lactation & Breastfeeding:

Use with caution — see notes

Discuss montelukast with your doctor while breastfeeding, especially if your baby is premature or has medical needs.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store in original packaging at room temperature, away from moisture and children.

⏱️ Missed Dose Protocol:

Follow the product leaflet — usually take the next scheduled dose and do not double up. Do not take extra medicine for an asthma attack.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Montelukast →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Montelukast Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/montelukast/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.